openPR Logo
Press release

Update on the New EU Medical Device Regulation and In Vitro Diagnostic Regulation

04-07-2017 09:06 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: SGS

/ PR Agency: Sugarloaf Marketing
Update on the New EU Medical Device Regulation and In Vitro

Eudamed, the European Database on Medical Devices, has published a timetable for the expected completion of legislation towards an amended Medical Device Regulation (MDR) and In Vitro Diagnostic Regulations (IVDR). According to the timetable, an official version of the new MDR and IVDR will probably be published in May 2017.

As part of this process, Eur-lex released the final draft of the amended MDR and IVDR on February 22, 2017. The drafts include instructions on the chemical requirements in the new regulations – in sections 10.4.1 and 10.4.5 of the draft MDR and section 10.3 in the draft IVDR. The MDR also contains special guidelines on phthalates and CMR or endocrine disruption substances.

The draft MDR also states that a label will be necessary if a device, part or material contains CMR 1A, 1B or EDCs in a concentration higher than 0.1% (w/w). In addition, instructions for use must be given as a precautionary measure if the device is intended for use by a patient group who may be considered particularly vulnerable to substances and/or materials within the device. The draft legislation singles out children and pregnant or breastfeeding women as vulnerable groups.

The full timetable, as released by Eudamed, is:

• End January 2017 – English version of the new MDR and IVDR
• Middle of February 2017 – English version and EU translations distributed to stakeholders
• Beginning of March 2017 – Council expected to accept the new versions
• Beginning of April 2017 – European Parliament adopts regulations
• End April 2017 – Formal publication
• End May 2017 – Official entry into force
• End May 2020 – MDR applicable
• End May 2022 – IVDR applicable

The revision and creation of a new European MDR and IVDR has been in discussion since 2012. It is expected that the official versions will enter into force in May 2017. This will create an applicable date of May 2020 for the new MDR, and 2022 for the new IVDR.

Stakeholders are advised to now consider the updated regulations to check their future compliance.

SGS Medical Devices Services
SGS’s medical device testing, certification, audit and training services help companies navigate the complexities of international medical device regulations to bring their products to market quickly whilst ensuring compliance with the required regulations and standards. Learn more about SGS’s Medical Devices Services (www.sgs.com/consumermedicaldevices)

SGS SafeGuardS keep you up to date with the latest news and developments in the consumer goods industry. Read the full Eudamed Releases Timetable to Update the EU’s Medical Device Regulation and in Vitro Diagnostic Regulation SafeGuardS. (www.sgs.com/en/news/2017/03/safeguards-04517-eudamed-releases-timetable-to-update-the-eu-medical-device-regulation)

Subscribe here, www.sgs.com/subscribesg, to receive SGS SafeGuardS direct to your inbox.

For further information contact:

Richie Chang
SGS Taiwan Ltd. Multi-Chemical Lab (Taipei) Asst. Manager
Tel: +886 2 22993279
Email: cts.media@sgs.com
Website: www.sgs.com/ee

About SGS
SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 90,000 employees, SGS operates a network of over 2,000 offices and laboratories around the world.

1, Mons Calpe
Chitcombe Road
Broad Oak
Rye
East Sussex
TN31 6EU

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Update on the New EU Medical Device Regulation and In Vitro Diagnostic Regulation here

News-ID: 494708 • Views:

More Releases from SGS

SGS Summarizes Impact of EU Postponement of RED Cybersecurity Regulation Enforce …
SGS, the world's leading testing, inspection and certification company, has published SafeGuardS 095.23 to help stakeholders understand the impact of the decision to postpone the enforcement of the Radio Equipment Directive (RED) delegated act for cybersecurity until 2025. The European Commission (EC) originally planned to enforce the delegated act from August 2024. However, delays in the preparation of harmonized standards have meant the EC has now taken the decision to enforce
SGS Issues SafeGuardS for US CPSC Direct Final Rule for Bedside Sleepers
SGS, the world's leading testing, inspection and certification company, has published a SafeGuardS covering a recent direct final rule for bedside sleepers issued by the US Consumer Products Safety Commission (CPSC). Direct final rule 16 CFR 1222 was published on May 9, 2023, revising the safety standard for bedside sleepers. It incorporates the latest version of ASTM F2906-23 (Standard Consumer Safety Specification for Bedside Sleepers) with a modification. The modification involves
SGS Announces Complementary Webinar to Help Businesses Navigate Post-Brexit European Requirements for PPE
SGS Announces Complementary Webinar to Help Businesses Navigate Post-Brexit Euro …
SGS, the world's leading testing, inspection and certification company, has announced a webinar to help companies operating in European personal protective equipment (PPE) markets understand the implications of Brexit and the best route towards compliance. "Personal Protective Equipment: overview of EU and UK requirements" will be offered in two sessions on February 9, 2023, at 10.00 CET and 16.00 CET. It is aimed at operators throughout the PPE value chain, including
Patented pest management products now available direct from manufacturer
01-11-2023 | Energy & Environment
SGS
Patented pest management products now available direct from manufacturer
In 2023, IPS is taking a new pathway in the distribution of the company's flagship products. It is now possible to purchase the CLTab and SPTab solutions under the Insectrac brand name directly from IPS, the manufacturer. The company behind these unique products is International Pheromone Systems a customer-orientated company with 35 years of experience in developing, producing, and supplying high-quality insect pheromone and kairomone formulations and associated trapping systems to a

All 5 Releases


More Releases for MDR

Managed Detection and Response (MDR) Market Drivers, Restraints, Opportunities, …
Managed detection and response (MDR) improves incident response capabilities and threat detection monitoring through a turnkey approach which detects threats that have evaded other controls. Risk and security management providers are understanding the importance of MDR services and its impact for their environments. New service providers have developed solutions to support businesses seeking to increase their incident response and threat detection capabilities. Additionally, MDR vendors deliver services for purchasers looking
Managed Detection and Response (MDR) Market – Growth Opportunities & Technolog …
MarketResearchReports.Biz announces addition of new report "Managed Detection and Response (MDR) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its database. The objectives of this study are as follows: To define, describe, and forecast the "Managed Detection and Response (MDR)" market by type, application, component, delivery model, end user, and region To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and industry-specific
Indian Retail Industry Poised for Big Growth Post MDR Withdrawal
Chennai, December 27, 2017: Come January 2018, retailers can rejoice as they don’t need to pay Merchant Discount Rate (MDR) charges to banks for every debit card payment they receive. The government’s recent decision to abolish MDR for small and medium retail merchants over the digital transactions through debit card up to Rs 2000 has come as a welcome relief for thousands of retail businesses across the country as they were
Managed Detection and Response (MDR) Market Investment Research Report 2025
Managed detection and response (MDR) improves incident response capabilities and threat detection monitoring through a turnkey approach which detects threats that have evaded other controls. Risk and security management providers are understanding the importance of MDR services and its impact for their environments. New service providers have developed solutions to support businesses seeking to increase their incident response and threat detection capabilities. Additionally, MDR vendors deliver services for purchasers looking
Paladion Recognized as a Representative Vendor in Gartner’s 2017 Market Guide …
Paladion—a global cyber defense company that provides managed detection and response services— today announced its placement in Gartner’s Market Guide for Managed Detection and Response as a representative vendor. Gartner identified Paladion as a representative vendor for its advanced threat detection and incident response capabilities using their proprietary security analytics and orchestration platform, which are capabilities profiled in this research. In this research, Gartner recommends IT security buyers: “Use MDR
Clinical Executives Meet to Discuss MDR at Popular Clinical Research Conference
Aligning Clinical Research Strategies with EU Medical Device Regulation, Providing Greater Data to Support Product Registration, Enhancing Clinical Budget (Berlin, Germany) – Q1 Production’s European Medical Device Clinical Research conference will return this January 23-24, 2017 to Berlin, Germany. The Medical Device Regulation’s impact on clinical operations will be discoursed, as more trials are now required by health authorities across the Union due to the re-registration of CE marked